Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
OwnerTorbjorn Lundstedt, Anna Skottner +1inventors
InventorsTorbjorn Lundstedt, Anna Skottner, Elisabeth Seifert
Life of this patent
Estimating the term…
Loading patent…
OwnerTorbjorn Lundstedt, Anna Skottner +1inventors
InventorsTorbjorn Lundstedt, Anna Skottner, Elisabeth Seifert
Estimating the term…
The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and the pharmacologically active salts thereof. 1
The use of a compound of general formula (I)
Use according to any one of the previous claims wherein one or more of R1, R2, R3, R4 and R5 are halogen atoms.
Use of a compound selected from:
Use as claimed in any one of the previous claims where additionally is present a label, preferably a radioactive label, or a toxic agent.
Dependencies are inferred from the claim text.